Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
Aline Renneville(Université Paris-Sud), Benjamin L. Ebert(Dana-Farber Cancer Institute), Jean‐Jacques Kiladjian(Délégation Paris 5), Stéphane de Botton(Université Paris-Saclay), Namrata D. Udeshi(Harvard University), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Rob S. Sellar(University College London), Steven A. Carr(Broad Institute), Kaushik Viswanathan(Dana-Farber Cancer Institute), Véronique Saada(Université Paris-Saclay), Alexander Tepper(Broad Institute), Thomas Clayton(Bristol-Myers Squibb (Switzerland)), Christophe Marzac(Institut Gustave Roussy), Mark Rolfe(Unknown), Mary E. Matyskiela(Bristol-Myers Squibb (Switzerland)), Daniel E. Grinshpun(Broad Institute), Pierre M. Jean Beltran(Broad Institute), Marie McConkey(Dana-Farber Cancer Institute), Jessica A. Gasser(Broad Institute), Sophie Cotteret(Institut Gustave Roussy), Jean‐Michel Cayuela(Inserm), Philip P. Chamberlain(NeoGenomics (United States))
Cited by 46
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k